H. Pruul

849 total citations
27 papers, 713 citations indexed

About

H. Pruul is a scholar working on Immunology, Infectious Diseases and Pharmacology. According to data from OpenAlex, H. Pruul has authored 27 papers receiving a total of 713 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Immunology, 11 papers in Infectious Diseases and 10 papers in Pharmacology. Recurrent topics in H. Pruul's work include Immune Response and Inflammation (11 papers), Antibiotics Pharmacokinetics and Efficacy (10 papers) and Antibiotic Resistance in Bacteria (8 papers). H. Pruul is often cited by papers focused on Immune Response and Inflammation (11 papers), Antibiotics Pharmacokinetics and Efficacy (10 papers) and Antibiotic Resistance in Bacteria (8 papers). H. Pruul collaborates with scholars based in Australia, United Kingdom and France. H. Pruul's co-authors include Peter J. McDonald, B L Wetherall, P. J. McDonald, Florence Depardieu, Jan Bell, Patrice Courvalin, Antonio Ferrante, C. S. Goodwin, Myron A. Leon and John J. Finlay‐Jones and has published in prestigious journals such as Clinical Infectious Diseases, Antimicrobial Agents and Chemotherapy and Infection and Immunity.

In The Last Decade

H. Pruul

27 papers receiving 650 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
H. Pruul Australia 15 236 207 196 195 138 27 713
N L King-Thompson United States 12 241 1.0× 198 1.0× 190 1.0× 232 1.2× 157 1.1× 15 854
A Gorea Israel 11 175 0.7× 196 0.9× 123 0.6× 123 0.6× 327 2.4× 26 752
Minako Araake Japan 14 96 0.4× 164 0.8× 228 1.2× 154 0.8× 249 1.8× 48 818
J. P. Maskell United Kingdom 17 150 0.6× 174 0.8× 195 1.0× 263 1.3× 145 1.1× 35 705
Joyce de Azavedo Canada 15 164 0.7× 115 0.6× 416 2.1× 296 1.5× 228 1.7× 19 914
R F D'Amato United States 15 94 0.4× 118 0.6× 322 1.6× 368 1.9× 103 0.7× 38 785
M F Newborg United States 6 126 0.5× 78 0.4× 117 0.6× 239 1.2× 73 0.5× 9 620
J Barnishan United States 11 79 0.3× 112 0.5× 143 0.7× 114 0.6× 80 0.6× 13 421
Stéphane Carryn Belgium 12 314 1.3× 266 1.3× 218 1.1× 255 1.3× 154 1.1× 21 756
M A Edelstein United States 18 215 0.9× 302 1.5× 177 0.9× 354 1.8× 302 2.2× 36 1.0k

Countries citing papers authored by H. Pruul

Since Specialization
Citations

This map shows the geographic impact of H. Pruul's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H. Pruul with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H. Pruul more than expected).

Fields of papers citing papers by H. Pruul

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H. Pruul. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H. Pruul. The network helps show where H. Pruul may publish in the future.

Co-authorship network of co-authors of H. Pruul

This figure shows the co-authorship network connecting the top 25 collaborators of H. Pruul. A scholar is included among the top collaborators of H. Pruul based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H. Pruul. H. Pruul is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Depardieu, Florence, et al.. (2004). VanD-Type Vancomycin-Resistant Enterococcus faecium and Enterococcus faecalis. Antimicrobial Agents and Chemotherapy. 48(10). 3892–3904. 59 indexed citations
2.
McDonald, Peter J. & H. Pruul. (2001). Tailoring antibiotic treatment to host immune status: The host, not the drug, determines outcome. Current Infectious Disease Reports. 3(4). 309–311. 1 indexed citations
3.
Pruul, H. & P. J. McDonald. (1993). Cefdinir-induced modification of the susceptibility of bacteria to the antibacterial activity of human serum and polymorphonuclear neutrophils. European Journal of Clinical Microbiology & Infectious Diseases. 12(3). 170–176. 10 indexed citations
4.
Pruul, H. & Peter J. McDonald. (1992). Potentiation of antibacterial activity of azithromycin and other macrolides by normal human serum. Antimicrobial Agents and Chemotherapy. 36(1). 10–16. 40 indexed citations
5.
McDonald, Peter J. & H. Pruul. (1991). Phagocyte uptake and transport of azithromycin. European Journal of Clinical Microbiology & Infectious Diseases. 10(10). 828–833. 104 indexed citations
6.
Pruul, H. & P. J. McDonald. (1990). Lomefloxacin-induced modification of the kinetics of growth of Gram-negative bacteria and susceptibility to phagocytic killing by human neutrophils. Journal of Antimicrobial Chemotherapy. 25(1). 91–101. 43 indexed citations
7.
Pruul, H., et al.. (1990). Hydrophobic characterisation of Helicobacter (Campylobacter) pylori. Journal of Medical Microbiology. 32(2). 93–100. 9 indexed citations
8.
Pruul, H., et al.. (1988). Enoxacin-induced modification of the susceptibility of bacteria to phagocytic killing. Journal of Antimicrobial Chemotherapy. 21(suppl B). 19–27. 12 indexed citations
9.
Pruul, H. & P. J. McDonald. (1988). Damage to bacteria by antibiotics in vitro and its relevance to antimicrobial chemotherapy: a historical perspective. Journal of Antimicrobial Chemotherapy. 21(6). 695–696. 19 indexed citations
10.
Pruul, H., et al.. (1988). Enhanced susceptibility of Gram-negative bacteria to phagocytic killing by human polymorphonuclear leucocytes after brief exposure to aztreonam. Journal of Antimicrobial Chemotherapy. 22(5). 675–686. 19 indexed citations
11.
Pruul, H., et al.. (1987). Interaction of Campylobacter pyloridis with human immune defence mechanisms. Journal of Medical Microbiology. 23(3). 233–238. 24 indexed citations
12.
Pruul, H., B L Wetherall, & Peter J. McDonald. (1986). In vitro killing of erythromycin-exposed group a streptococci by polymorphonuclear leukocytes. European Journal of Clinical Microbiology & Infectious Diseases. 5(4). 405–410. 14 indexed citations
13.
Finlay‐Jones, John J., et al.. (1984). Opsonins in normal mouse serum for the phagocytic killing of Proteus mirabilis by murine neutrophils.. PubMed. 65(6). 711–8. 6 indexed citations
14.
Pruul, H., B L Wetherall, & Peter J. McDonald. (1982). The effect of exposure of staphylococcus aureus to penicillin on susceptibility to the bactericidal activity of human leukocytes. Pathology. 14(3). 263–267. 4 indexed citations
15.
Pruul, H., B L Wetherall, & P. J. McDonald. (1981). Enhanced susceptibility of Escherichia coli to intracellular killing by human polymorphonuclear leukocytes after in vitro incubation with chloramphenicol. Antimicrobial Agents and Chemotherapy. 19(6). 945–951. 14 indexed citations
16.
McDonald, Peter J., B L Wetherall, & H. Pruul. (1981). Postantibiotic Leukocyte Enhancement: Increased Susceptibility of Bacteria Pretreated with Antibiotics to Activity of Leukocytes. Clinical Infectious Diseases. 3(1). 38–44. 147 indexed citations
17.
Pruul, H. & Peter J. McDonald. (1979). Enhancement of leukocyte activity against Escherichia coli after brief exposure to chloramphenicol. Antimicrobial Agents and Chemotherapy. 16(6). 695–700. 25 indexed citations
18.
Pruul, H. & Myron A. Leon. (1978). Properties of a cell-bound homogeneous murine IgM anti-dextran-V. Immunochemistry. 15(10-11). 721–726. 6 indexed citations
19.
Pruul, H., et al.. (1972). Interaction of Complement and Polymyxin with Gram-Negative Bacteria. Infection and Immunity. 6(5). 709–717. 24 indexed citations
20.
Pruul, H., et al.. (1971). Sensitization of Complement-Resistant Smooth Gram-Negative Bacterial Strains. Infection and Immunity. 3(3). 365–372. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by N L King-Thompson Breakdown of academic impact, for papers by A Gorea Breakdown of academic impact, for papers by Minako Araake Breakdown of academic impact, for papers by J. P. Maskell Breakdown of academic impact, for papers by Joyce de Azavedo Breakdown of academic impact, for papers by R F D'Amato Breakdown of academic impact, for papers by M F Newborg Breakdown of academic impact, for papers by J Barnishan Breakdown of academic impact, for papers by Stéphane Carryn Breakdown of academic impact, for papers by M A Edelstein
Rankless by CCL
2026